+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

From
From
From
Autism - Global Clinical Trials Review, 2022 - Product Thumbnail Image

Autism - Global Clinical Trials Review, 2022

  • Clinical Trials
  • January 2022
  • 419 Pages
  • Global
From
From
Hypoglycemia - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Hypoglycemia - Global Drug Forecast and Market Analysis to 2030

  • Report
  • November 2021
  • 124 Pages
  • Global
From
Migraine - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Migraine - Global Drug Forecast and Market Analysis to 2030

  • Report
  • November 2021
  • 131 Pages
  • Global
From
Rheumatoid Arthritis - Epidemiology Forecast to 2029 - Product Thumbnail Image

Rheumatoid Arthritis - Epidemiology Forecast to 2029

  • Report
  • November 2020
  • 46 Pages
  • Global
From
From
Dry Eye Syndrome: Epidemiology Forecast to 2028 - Product Thumbnail Image

Dry Eye Syndrome: Epidemiology Forecast to 2028

  • Report
  • May 2020
  • 35 Pages
  • Global
From
Alzheimer's Disease: Epidemiology Forecast to 2028 - Product Thumbnail Image

Alzheimer's Disease: Epidemiology Forecast to 2028

  • Report
  • May 2020
  • 47 Pages
  • Global
From
From
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more